Article
Effect of the Asp298 variant of endothelial nitric oxide synthase on survival for patients with congestive heart failure.
Circulation - 1 Apr 2003
McNamara Dennis M, Holubkov Richard, Postava Lisa, Ramani Ravi, Janosko Karen, Mathier Michael, MacGowan Guy A, Murali Srinivas, Feldman Arthur M, London Barry
Abstract excerpt
BACKGROUND: Significant variation exists within the endothelial nitric oxide synthase (NOS3) gene that may influence cardiovascular risk. The Asp298 variant of NOS3 has a shorter half-life in endothelial cells. Given the importance of nitric oxide in the heart failure syndrome, we evaluated the effect of this variant on event-free survival in a population with systolic dysfunction. METHODS AND RESULTS: Four...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
